Introduction
albumin 35 g/l, serum protein electrophoresis without abnormality. Haemoglobin was 96 g/l, WBC count Chronic lymphocytic leukaemia (CLL) is a haematol-33 000/mm3 with 80% of mature looking lymphocytes, ogical disorder characterized by proliferation of mono-platelets 293 000/mm3. Blood glucose, hepatic tests and clonal B lymphocytes blocked at an intermediate level lipids were normal. Urinary protein excretion was of differentiation. It may be responsible for renal 2.6 g/day; the urine sediment revealed microscopic manifestations common to any haematological malig-haematuria. nancy: acute neoplastic interstitial nephritis, uric acid IgG was 13 g/l (N 6-12 ), IgM 2.8 g/l (N 0.5-1.5), precipitation, secondary amyloïdosis. About sixty cases IgA 1.13 g/l (N 0.8-2.5); serum and urine immunofixof glomerular lesions have been published [1] [2] [3] [4] [5] . The ations revealed no M-component. Cryoglobulins and most frequent are type I and II membranoproliferative rheumatoid factor were negative on three occasions. glomerulonephritis (GN ); less frequent are membran-Antinuclear antibodies and the other autoantibodies ous GN, focal or diffuse proliferative GN, and fibrillar were not present. A direct Coombs test was neg-GN. Minimal-change disease (MCD) and focal or ative. Total complement was 65 UI (N 60±15 UI ), diffuse glomerulosclerosis have also been described. C3 1.23 g/l (N 0.8-1.5), C4 0.4 g/l ( N 0.17-0.38), The pathophysiology of these GN may be related to C1 q 0.28 g/l (N 0.1-0.27), activated C3 0.2 g/l (N the glomerular deposition of the monoclonal compon-0.08-0.24). Circulating immune complexes were negaent ( M-component) secreted by the B-cell clone.
tive. No antibasement membrane antibodies were evidWe report a case of crescentic GN with antineutro-enced by ELISA. Perinuclear ANCA were shown to phil cytoplasmic antibody (ANCA) during the evolu-be present by indirect immunofluorescence at a 1/200 tion of a CLL. The pathophysiology of this form of dilution; ELISA was positive for antimyeloperoxydase GN is different from those already described since it at 50 U/ml (N<7 U/ml ) and negative for antimay involve a disturbance in cellular immunity. proteinase 3. Renal ultrasound revealed two normal kidneys. Percutaneous renal biopsy ( 16 glomeruli) by light-microscopy showed severe extracapillary prolif-
Case report
eration affecting 15 glomeruli with cellular or fibrocellular crescents. There was no endocapillary A 68-year-old woman was referred in May 1996 for proliferation and no deposits. The interstitium was not acute renal failure discovered during the systematic infiltrated by lymphocytes. Blood vessels were normal. survey of a CLL. This patient was diagnosed as stage The immunofluorescence revealed no fixation of any A (Binet classification) CLL in 1991. At this time, antiserum tested. medullar lymphocytosis was 47% with 80% of B Treatment was initiated and repeated every 3 weeks lymphocytic monoclonal cells expressing kappa, mu, with prednisone 60 mg/m2 for 5 days, oncovin 2 mg at delta, and CD5+ antigens. Her renal function was D1, adriamycin 30 mg/m2 at D1 and cyclophospham-377 mmol/l. Renal function improved dramatically not surprising to find ANCA in our patient since these antibodies are usually detected in diseases with cellafter three cures: creatinine was 203 mmol/l. mediated immune crescentic GN such as Wegener's granulomatosis [9] . In other words ANCA positivity Discussion may be a reflection of the T-cell defect that induces cell-mediated immune crescentic GN. Recently a renal antigen has been identified that is related to a lysosomal We report the first case of crescentic GN with ANCA during CLL. This case raises two questions: is it a glycoprotein of neutrophil granulocytes and that reacts with ANCA from patients with crescentic GN [10 ] . fortuitous association of the two diseases? If not, what is the pathophysiological link between the two diseases CLL-induced T-suppressor-cell defect for this antigen could have induced the glomerular lesions. This case relative to ANCA positivity?
A fortuitous association of the two diseases is very demonstrates that, besides glomerular lesions induced by the M-component, CLL can be complicated by unlikely for several reasons: first, the occurrence of glomerular involvement was concomitant with a flare cell-mediated immune GN.
Note added in proof: In the November issue of of the haematological disorder as reflected by anaemia. Second, we could not find another aetiology for this NDT, Tisler et al. reported a case of pauci-immune crescentic GN associated with p-ANCA positivity in a pauci-immune crescentic GN. The only differential diagnosis could have been an idiopathic pauci-immune fludarabine-treated CLL. This case is not quite different from ours even though, in Tisler's report, a clearcrescentic GN, now referred to as renal vasculitis, but the above considerations argue against this possibility. cut relationship exists between the occurrence of the crescentic GN and the treatment with fludarabine. In Even if a coincidence of the two diseases cannot be fully excluded, the rarity of pauci-immune crescentic fact fludarabine may have accentuated the T-cell defect that induces immune crescentic GN. GN and the 60 cases of CLL-associated GN published to date are two more arguments for a non-fortuitous association between CLL and the crescentic GN we observed.
